Clinical Trials Directory

Trials / Conditions / Recurrent Urethral Cancer

Recurrent Urethral Cancer

12 registered clinical trials studyying Recurrent Urethral Cancer.

StatusTrialSponsorPhase
TerminatedAfatinib in Advanced Refractory Urothelial Cancer
NCT02122172
University of ChicagoPhase 2
CompletedFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe
NCT01846520
City of Hope Medical CenterN/A
WithdrawnGemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and
NCT01639521
University of Southern CaliforniaPhase 2
CompletedPazopanib in Treating Patients With Metastatic Urothelial Cancer
NCT00471536
National Cancer Institute (NCI)Phase 2
CompletedGemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Functi
NCT00478361
M.D. Anderson Cancer CenterPhase 2
CompletedVEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium
NCT00407485
National Cancer Institute (NCI)Phase 2
TerminatedSorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
NCT00112905
National Cancer Institute (NCI)Phase 2
CompletedPhase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transition
NCT00072150
National Cancer Institute (NCI)Phase 2
TerminatedTrastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothe
NCT00004856
National Cancer Institute (NCI)Phase 2
CompletedIxabepilone in Treating Patients With Advanced Urinary Tract Cancer
NCT00021099
National Cancer Institute (NCI)Phase 2
CompletedArsenic Trioxide in Treating Patients With Urothelial Cancer
NCT00009867
National Cancer Institute (NCI)Phase 2
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1